{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:07:16Z","timestamp":1774555636138,"version":"3.50.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Prevalence of pediatric urolithiasis is increasing, which is definitively visible in increasing numbers of presentations in emergency or outpatient clinics. In pediatric patients, a genetic or metabolic disease has to be excluded, so that adequate treatment can be installed as early as possible. Only then either recurrent stone events and chronic or even end-stage kidney disease can be prevented.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The genetic background of mostly monogenic kidney stone diseases was unravelled recently. In hypercalcuria, for example, the commonly used definition of idiopathic hypercalciuria was adopted to the genetic background, here three autosomal recessive hereditary forms of CYP24A1, SLC34A1 and SLC34A3 associated nephrocalcinosis\/urolithiasis with elevated 1.25-dihydroxy-vitamin D3 (1.25-dihydroxy-vitamin D3) (calcitriol) levels. In addition either activating or inactivating mutations of the calcium-sensing receptor gene lead either to hypocalcemic hypercalciuria or hypercalcemic hypocalciuria. In primary hyperoxaluria, a third gene defect was unravelled explaining most of the so far unclassified patients. In addition, these findings lead to new treatment options, which are currently evaluated in phase III studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Kidney stones are not the disease itself, but only its first symptom. The underlying disease has to be diagnosed in every pediatric patient with the first stone event.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000848","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:32:18Z","timestamp":1574901138000},"page":"273-283","source":"Crossref","is-referenced-by-count":23,"title":["Inherited conditions resulting in nephrolithiasis"],"prefix":"10.1097","volume":"32","author":[{"given":"Bernd","family":"Hoppe","sequence":"first","affiliation":[{"name":"Pediatric Nephrology, University Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Martin-Higueras","sequence":"additional","affiliation":[{"name":"Institute of Experimental Immunology, University Hospital Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.juro.2007.02.002","article-title":"Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome","volume":"177","author":"VanDervoort","year":"2007","journal-title":"J Urol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.juro.2010.05.018","article-title":"Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals","volume":"184","author":"Routh","year":"2010","journal-title":"J Urol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"c45","DOI":"10.1159\/000080251","article-title":"Aetiological factors in paediatric urolithiasis","volume":"98","author":"van\u2019t Hoff","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpeds.2010.02.004","article-title":"Increasing incidence of kidney stones in children evaluated in the emergency department","volume":"157","author":"Sas","year":"2010","journal-title":"J Pediatr"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s002470050539","article-title":"Observer reliability in grading nephrocalcinosis on ultrasound examinations in children","volume":"29","author":"Dick","year":"1999","journal-title":"Pediatr Radiol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ki.2011.336","article-title":"Nephrocalcinosis and urolithiasis in children","volume":"80","author":"Habbig","year":"2011","journal-title":"Kidney Int"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fped.2018.00098","article-title":"Nephrolithiasis and nephrocalcinosis in childhood\u2014risk factor-related current and future treatment options","volume":"6","author":"Weigert","year":"2018","journal-title":"Front Pediatr"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.urology.2008.12.079","article-title":"Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation","volume":"74","author":"Novak","year":"2009","journal-title":"Urology"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00467-008-1073-x","article-title":"Diagnostic examination of the child with urolithiasis or nephrocalcinosis","volume":"25","author":"Hoppe","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00467-008-0960-5","article-title":"History, epidemiology and regional diversities of urolithiasis","volume":"25","author":"L\u00f3pez","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-008-1085-6","article-title":"Nephrolithiasis related to inborn metabolic diseases","volume":"25","author":"Cochat","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/B978-0-323-04883-5.50039-8","article-title":"Urolithiasis and nephrocalcinosis in childhood","author":"Hoppe","year":"2008","journal-title":"Comprehensive pediatric nephrology"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000455698","article-title":"Obesity and kidney disease: hidden consequences of the epidemic","volume":"135","author":"Kovesdy","year":"2017","journal-title":"Nephron"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11255-009-9623-0","article-title":"Clinical and metabolic risk factor evaluation in young adults with kidney stones","volume":"42","author":"Spivacow","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.ajkd.2004.06.030","article-title":"Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms","volume":"44","author":"Gambaro","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13353-017-0397-2","article-title":"Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases","volume":"58","author":"Pronicka","year":"2017","journal-title":"J Appl Genet"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"e13715","DOI":"10.14814\/phy2.13715","article-title":"Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations","volume":"6","author":"Fearn","year":"2018","journal-title":"Physiol Rep"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3","volume":"78","author":"Lorenz-Depiereux","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R21-20230918","first-page":"458","article-title":"Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2. A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia","volume":"7","author":"Roszko","year":"2016","journal-title":"Front Physiol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1687-9856-2012-13","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"2012","author":"Tonyushkina","year":"2012","journal-title":"Int J Pediatr Endocrinol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"Genetics of hyperparathyroidism including parathyroid cancer","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJMoa010369","article-title":"Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria","volume":"346","author":"Borghi","year":"2002","journal-title":"N Engl J Med"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00467-004-1422-3","article-title":"Evaluation and treatment of pediatric idiopathic urolithiasis-revisited","volume":"19","author":"Alon","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00240-012-0539-2","article-title":"Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia","volume":"41","author":"Karsli","year":"2013","journal-title":"Urolithiasis"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"F592","DOI":"10.1152\/ajprenal.00116.2013","article-title":"Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria","volume":"305","author":"Bergsland","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/j.ajkd.2008.08.021","article-title":"Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial","volume":"52","author":"Blanchard","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ki.2014.222","article-title":"Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type","volume":"86","author":"Mandrile","year":"2014","journal-title":"Kidney Int"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrneph.2012.113","article-title":"An update on primary hyperoxaluria","volume":"8","author":"Hoppe","year":"2012","journal-title":"Nature Rev Nephrol"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1159\/000080254","article-title":"Molecular aetiology of primary hyperoxaluria type 1","volume":"98","author":"Danpure","year":"2004","journal-title":"Nephron Exp Nephrol"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00467-012-2329-z","article-title":"Hereditary causes of kidney stones and chronic kidney disease","volume":"28","author":"Edvardsson","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","article-title":"The primary hyperoxalurias","volume":"75","author":"Hoppe","year":"2009","journal-title":"Kidney Int"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/humu.9200","article-title":"Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2","volume":"22","author":"Cregeen","year":"2003","journal-title":"Hum Mutat"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajhg.2010.07.023","article-title":"Mutations in DHDPSL are responsible for primary hyperoxaluria type III","volume":"87","author":"Belostotsky","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ejhg.2012.139","article-title":"Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies","volume":"21","author":"Beck","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00467-017-3731-3","article-title":"Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III","volume":"32","author":"Ventzke","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2215\/CJN.06820613","article-title":"Vitamin B6 in primary hyperoxaluria I: First prospective trial after 40 years of practice","volume":"9","author":"Hoyer-Kuhn","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/sj.ki.5001806","article-title":"Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1","volume":"70","author":"Illies","year":"2006","journal-title":"Kidney Int"},{"key":"R42-20230918","first-page":"1475","article-title":"Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experience","volume":"20","author":"Compagnon","year":"2014","journal-title":"Liver Transpl"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/petr.12243","article-title":"Combined liver-kidney transplantation for hyperoxaluria type II?","volume":"18","author":"Filler","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ajt.14596","article-title":"Invited response to recurrence of oxalate nephropathy after isolated kidney transplantation for primary hyperoxaluria type 2","volume":"18","author":"Dhondup","year":"2018","journal-title":"Am J Transplant"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2215\/CJN.02810315","article-title":"Predictors of incident ESRD among patients with primary hyperoxaluria presenting prior to kidney failure","volume":"11","author":"Zhao","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1046\/j.1523-1755.2003.t01-4-00001.x","article-title":"Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants","volume":"63","author":"Sikora","year":"2003","journal-title":"Kidney Int"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00467-008-0960-5","article-title":"History, epidemiology and regional diversities of urolithiasis","volume":"25","author":"L\u00f3pez","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-004-1663-1","article-title":"Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up","volume":"20","author":"Knoll","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0022-5347(01)65451-X","article-title":"Medical treatment of cystinuria: results of contemporary clinical practice","volume":"156","author":"Chow","year":"1996","journal-title":"J Urol"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-5347(01)67256-2","article-title":"Clinical effect of captopril on the formation and growth of cystine calculi","volume":"154","author":"Cohen","year":"1995","journal-title":"J Urol"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ki.2010.389","article-title":"Pharmacotherapy of urolithiasis: evidence from clinical trials","volume":"79","author":"Moe","year":"2011","journal-title":"Kidney Int"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00303750","article-title":"Investigations of the efficacy of ascorbic acid therapy in cystinuria","volume":"19","author":"Birwe","year":"1991","journal-title":"Urol Res"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/0140-6736(92)90569-O","article-title":"2,8-Dihydroxyadenine urolithiasis, an underdiagnosed disease","volume":"339","author":"Ceballos-Picot","year":"1992","journal-title":"Lancet"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00467-006-0267-3","article-title":"Xanthinuria type I: a rare cause of urolithiasis","volume":"22","author":"Arikyants","year":"2007","journal-title":"Pediatr Nephrol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:14:28Z","timestamp":1695003268000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000848","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}